|Bid||71.12 x 1000|
|Ask||71.74 x 44000|
|Day's range||81.77 - 83.32|
|52-week range||66.72 - 92.97|
|PE ratio (TTM)||11.45|
|Earnings date||31 Jul 2017|
|Dividend & yield||3.30 (3.50%)|
|1y target est||86.06|
Reporting EN This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible ...
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général ...
AstraZeneca plc shares rose after the company reportedly confirmed that its CEO is not quitting the company to join the generic drug-maker, Teva Pharmaceutical Industries Limited (TEVA).